As innovative drugs, the regulations of biological drug product are complex and various differing from types, attributing to distinguished product complexity, manufacturing processes, and end-user application.
Therefore, biosafety and quality control remain critical factors in biologics registration.
Leveraging its multi-platform testing capabilities, BRC Biotechnology offers comprehensive biosafety testing services according to different kinds of biologics to expedite global IND/BLA submissions.
Comprehensive Capabilities Across Diverse Modalities
